GPT Healthcare debuts on the exchange; closes at premium

Mumbai, 29th February 2024 (GNI): L-R: Mr. Atul Tantia, Group CFO, Mr. Girish Joshi, Chief Listing and Trading Development, BSE, Mr. Dwarika Prasad Tantia, Chairman and Mr. Anurag Tantia, Director of GPT Healthcare Limited (ILS Hospitals) at prestigious Listing ceremony, BSE in Mumbai – photo by GNI

GPT Healthcare debuts on the exchange; closes at premium

Mumbai, 29th February 2024 (GNI): Shares of GPT Healthcare which runs hospitals under the ILS Hospital brand made its debut on the exchange to close at a premium of 7.93%.

The scrip listed Rs 216.15 per share on BSE and Rs 215 per share on NSE, at a premium of 16.21% and 15.59% respectively. The company’s share price closed at Rs 200.75 per share on the BSE, a 7.93% premium, and at Rs 200.25 per share on the NSE, a 6.86% premium.

As per NSE, the total quantity traded stood at 207.43 lakh shares, on BSE the total Quantity stood at 11.58 lakh shares. Total Turnover (BSE+NSE) on Day 1 stood at Rs 454.44 crore.

The Market Capitalization of the Company at today’s closing price stood at Rs. 1647.25 Crore as per BSE and Rs. 1643.15 Crore as per NSE.

GPT Healthcare, founded by Dwarika Prasad Tantia and Dr Om Tantia started with a 8 bed hospital at Salt Lake, Kolkata in 2000. Today it operates four full service multispecialty hospitals, with a total capacity of 561 beds and attends to over 35 specialties and super specialties such as internal medicine, diabetology, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurology, neurosurgery, paediatrics and neonatology.

Dr. Om Tantia, has over 4 decades of experience as a surgeon and is a specialist in the field of laparoscopic surgery. He has been the president of the Association of Minimal Access Surgeons of India along with multiple accolades to his credit, including the honorary professorship bestowed by the Indian Medical Association.

Its total income increased 7.3% to Rs 3610.37 million in fiscal year 2023 from Rs 3374.15 million in fiscal year 2022, primarily due to the increases in income from hospital services, aided by increase in patient volume; increase in income from pharmacy sales.

For the six months ended September 30, 2023, revenue from operations stood at Rs 2,041.76 million and net profit at Rs 234.85 million.ends GNI